A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Clinical trial NCT02138734 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02138734
- Sponsor
- ImmunityBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-21
- Primary completion
- 2026-09-30
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.